DiFabio Andrea — SEC Form 4 filings
SEC reporting owner CIK 1692506. 5 Form 4 filings on record with FilingPulse; latest filed 2026-03-13.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-03-12 to 2026-03-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 3,949 shares, $230,814 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 2,607 shares @ $60.11 ($156,702) in Xenon Pharmaceuticals Inc., filed 2026-03-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. (XENE) | Chief Legal Officer | 5 | — | 2 legs · 3,949 sh · $230,814 | 10 |
Form 4 filings — DiFabio Andrea
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-13 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Option exercise (M): 3,750 · Sale (S): 1,342 @ $55.23 · Option exercise (M): 3,750 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Option exercise (M): 7,500 · Sale (S): 2,607 @ $60.11 · Grant/award (A): 7,500 (derivative) @ $0 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Grant/award (A): 80,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Grant/award (A): 80,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1692506 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →